Enhancing immunity to HIV through APOBEC.
Harris
Reuben S
RS
Department of Biochemistry, Molecular Biology and Biophysics, Institute for Molecular Virology and Beckman Center for Genome Engineering, University of Minnesota, Minneapolis, Minnesota 55455, USA. rsh@umn.edu
D000071480:APOBEC-3G Deaminase; D019380:Anti-HIV Agents / Q000276:immunology / Q000627:therapeutic use*; D003564:Cytidine Deaminase / Q000235:genetics / Q000276:immunology*; D043525:Cytosine Deaminase / Q000037:antagonists & inhibitors* / Q000276:immunology*; D015658:HIV Infections / Q000276:immunology* / Q000517:prevention & control*; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D006801:Humans; D007113:Immunity, Innate / Q000187:drug effects / Q000276:immunology*; D054320:vif Gene Products, Human Immunodeficiency Virus / Q000276:immunology*
D019380:Anti-HIV Agents; D054320:vif Gene Products, Human Immunodeficiency Virus; D043525:Cytosine Deaminase; D000071480:APOBEC-3G Deaminase; C464924:APOBEC3G protein, human; D003564:Cytidine Deaminase